Cardiol Therapeutics Inc(CRDL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CRDL Cardiol Therapeutics Inc

Post-Mkt 09-25 17:16:11 EDT

1.71

-0.02

-1.16%

盘后1.74

+0.03+1.81%

16:14 EDT

High1.75	Low1.67	Vol889.56K
Open1.75	D1 Closing1.73	Amplitude4.62%
Mkt Cap208.62M	Tradable Cap165.30M	Total Shares122.00M
T/O1.52M	T/O Rate0.92%	Tradable Shares96.67M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"CRDL","market":"US","secType":"STK","nameCN":"Cardiol Therapeutics Inc","latestPrice":1.71,"timestamp":1790366400000,"preClose":1.73,"halted":0,"volume":889558,"hourTrading":{"tag":"盘后","latestPrice":1.7409,"preClose":1.71,"latestTime":"16:14 EDT","volume":4974,"amount":8538.3241314,"timestamp":1790367256733,"change":0.0309,"changeRate":0.01807,"amplitude":0.019006},"delay":0,"changeRate":-0.011560693641618507,"floatShares":96666299,"shares":122000000,"eps":-0.236039,"marketStatus":"Post-Mkt","change":-0.02,"latestTime":"09-25 17:16:11 EDT","open":1.7499,"high":1.75,"low":1.67,"amount":1515728,"amplitude":0.046243,"askPrice":1.71,"askSize":461,"bidPrice":1.65,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.236039,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1790380800000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":1.73,"preHourTrading":{"tag":"盘前","latestPrice":1.66,"preClose":1.73,"latestTime":"09:18 EDT","volume":146,"amount":245.17420840000003,"timestamp":1790342326000,"change":-0.07,"changeRate":-0.040462,"amplitude":0.052023},"postHourTrading":{"tag":"盘后","latestPrice":1.7409,"preClose":1.71,"latestTime":"16:14 EDT","volume":4974,"amount":8538.3241314,"timestamp":1790367256733,"change":0.0309,"changeRate":0.01807,"amplitude":0.019006},"volumeRatio":0.753843,"impliedVol":2.5347,"impliedVolPercentile":0.996},"requestUrl":"/m/hq/s/CRDL/wiki","defaultTab":"wiki","newsList":[{"id":"2667988878","title":"Cardiol Therapeutics receives over $7M in proceeds from warrant exercise","url":"https://stock-news.laohu8.com/highlight/detail?id=2667988878","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667988878?lang=en_us&edition=fundamental","pubTime":"2026-09-16 19:30","pubTimestamp":1789558217,"startTime":"0","endTime":"0","summary":"Cardiol Therapeutics (CRDL) is pleased to announce it has received proceeds of over $7M from the exercise of outstanding common share purchase warr...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cardiol-therapeutics-receives-over-7m-in-proceeds-from-warrant-exercise-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cardiol-therapeutics-receives-over-7m-in-proceeds-from-warrant-exercise-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4007","BK4139","LENZ","CRDL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667004106","title":"Press Release: Cardiol Therapeutics Announces Warrant Exercise for over USD $7 Million in Proceeds","url":"https://stock-news.laohu8.com/highlight/detail?id=2667004106","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667004106?lang=en_us&edition=fundamental","pubTime":"2026-09-16 19:27","pubTimestamp":1789558020,"startTime":"0","endTime":"0","summary":"-- Proceeds strengthen balance sheet ahead of pivotal Phase III MAVERIC. trial data readout in recurrent pericarditis and extends cash runway into","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","CRDL","BK4555","BK4139","LENZ","BK4588","EUFX","BK4604","BK4099","BK4539","03160","TM","CROC","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666164155","title":"Cardiol Therapeutics files $150M preliminary base shelf prospectus","url":"https://stock-news.laohu8.com/highlight/detail?id=2666164155","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666164155?lang=en_us&edition=fundamental","pubTime":"2026-09-11 05:05","pubTimestamp":1789074332,"startTime":"0","endTime":"0","summary":"Cardiol Therapeutics (CRDL) announced that it has filed a preliminary short form base shelf prospectus with the securities regulatory authorities i...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cardiol-therapeutics-files-150m-preliminary-base-shelf-prospectus-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cardiol-therapeutics-files-150m-preliminary-base-shelf-prospectus-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CRDL","LENZ","BK4139","BK4007","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662791991","title":"Cardiol Therapeutics initiated with a Buy at B. Riley","url":"https://stock-news.laohu8.com/highlight/detail?id=2662791991","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662791991?lang=en_us&edition=fundamental","pubTime":"2026-08-26 17:15","pubTimestamp":1787735715,"startTime":"0","endTime":"0","summary":"B. Riley initiated coverage of Cardiol Therapeutics (CRDL) with a Buy rating and $11 price target The firm believes the company’s lead candidate, C...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cardiol-therapeutics-initiated-with-a-buy-at-b-riley-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cardiol-therapeutics-initiated-with-a-buy-at-b-riley-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CRDL","LENZ","BK4539","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659953761","title":"Cardiol Therapeutics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2659953761","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659953761?lang=en_us&edition=fundamental","pubTime":"2026-08-14 07:02","pubTimestamp":1786662168,"startTime":"0","endTime":"0","summary":"Cardiol Therapeutics Inc reports results for the quarter ended June 30 - Earnings SummaryCardiol Therapeutics IncCRDL.TOreported a quarterly adjusted loss of 5 cents per share for the quarter ended Ju","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nL8N44A2FQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRDL","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659163053","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2659163053","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659163053?lang=en_us&edition=fundamental","pubTime":"2026-08-13 22:50","pubTimestamp":1786632611,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on PDS Biotechnology (PDSB), Cardiol Therapeutics (CRDL...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-300?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-300?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CRDL","BK4007","PDSB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659158478","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2659158478","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659158478?lang=en_us&edition=fundamental","pubTime":"2026-08-13 18:00","pubTimestamp":1786615200,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.Company                                   Symbol     Quarter  Mean  Report Time. ·ADC Ther. Ltd                                   2Q      (.22)   7:30 AM. ·Applied Ind Tech                                 4Q      2.92    6:30 AM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADCT","AMAT","AVAH","BRUN","CAN","CLBT","VIPS","BTBT","DEFT","BIRK","CLRB","EVTL","ELMT","CELC","ACOG","AEBI","ABEO","STNE","BSP","CAPR","AVR","ASND","AIT","BEAT","CRMD","BAK","ALH","ARX","AEYE","BLTE","EU","AIRO","DCGO","DARE","DLO","DRUG","FBRX","CAAP","CRDL","BZAI","BAP","BN","ESEA","CAMP","ETON","AIRJ","ACXP","ARCO","DDS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658413952","title":"Cardiol Therapeutics Inc Expected to Post a Loss of 8 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2658413952","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658413952?lang=en_us&edition=fundamental","pubTime":"2026-08-11 05:39","pubTimestamp":1786397944,"startTime":"0","endTime":"0","summary":"Cardiol Therapeutics Inc <CRDL.TO> expected to post a loss of8cents a share - Earnings PreviewCardiol Therapeutics IncCRDL.TOis expected to  show no change in quarterly revenue when it reports  result","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL8N44723M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CRDL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651251100","title":"H.C. Wainwright Remains a Buy on Cardiol Therapeutics (CRDL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2651251100","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651251100?lang=en_us&edition=fundamental","pubTime":"2026-07-15 00:15","pubTimestamp":1784045722,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Brandon Folkes reiterated a Buy rating on Cardiol Therapeutics today and set a price target of $9.00. Folkes covers the Hea...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-remains-a-buy-on-cardiol-therapeutics-crdl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-remains-a-buy-on-cardiol-therapeutics-crdl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CRDL","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646872749","title":"Press Release: Cardiol Therapeutics Reports Results of 2026 Annual General Meeting of Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2646872749","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646872749?lang=en_us&edition=fundamental","pubTime":"2026-06-25 19:27","pubTimestamp":1782386820,"startTime":"0","endTime":"0","summary":"TORONTO, June 25, 2026 /PRNewswire/ - Cardiol Therapeutics Inc.   , a late-stage life sciences company advancing anti-inflammatory and anti-fibrotic therapies for heart disease, announces the results from its Annual General Meeting of Shareholders  held virtually via live audio webcast on June 24, 2026. Shareholders voted overwhelmingly in favour of all Management resolutions proposed in the Company's Management Information Circular dated May 7, 2026.Resolutions proposed and approved at the AGM were:-- The election of the following directors for the ensuing year: Dr.Guillermo Torre-Amione, David Elsley, Chris Waddick, Teri Loxam, Dr.Timothy Garnett, Jennifer Chao, Peter Pekos, and Colin Stott.-- The appointment of BDO Canada LLP as auditors of the Company for the next. current fiscal year and the authorization of the Directors of the Company. to fix the remuneration to be paid to the auditors.The results of the voting on the election of Directors are as follows:Nominees                ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4139","03160","LENZ","BK4555","BK4007","BK4539","BK4604","TM","BK4099","BK4585","CRDL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638544592","title":"H.C. Wainwright Keeps Their Buy Rating on Cardiol Therapeutics (CRDL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2638544592","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638544592?lang=en_us&edition=fundamental","pubTime":"2026-05-27 01:54","pubTimestamp":1779818062,"startTime":"0","endTime":"0","summary":"In a report released today, Brandon Folkes from H.C. Wainwright maintained a Buy rating on Cardiol Therapeutics, with a price target of $9.00. Acco...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-keeps-their-buy-rating-on-cardiol-therapeutics-crdl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-keeps-their-buy-rating-on-cardiol-therapeutics-crdl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CRDL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634604184","title":"Cardiol Therapeutics Inc  expected to post a loss of 8 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2634604184","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634604184?lang=en_us&edition=fundamental","pubTime":"2026-05-09 06:13","pubTimestamp":1778278387,"startTime":"0","endTime":"0","summary":"Cardiol Therapeutics Inc  expected to post a loss of8cents a share - Earnings Preview Cardiol Therapeutics Inc CRDL.TO  is expected to  show no change in quarterly revenue when it reports  results on ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nL8N41L2S8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRDL","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625950987","title":"Analysts Offer Insights on Healthcare Companies: Neurogene (NGNE), Alzamend Neuro (ALZN) and Cardiol Therapeutics (CRDL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2625950987","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625950987?lang=en_us&edition=fundamental","pubTime":"2026-04-08 01:20","pubTimestamp":1775582407,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Neurogene (NGNE), Alzamend Neuro (ALZN) and Cardiol ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-neurogene-ngne-alzamend-neuro-alzn-and-cardiol-therapeutics-crdl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-neurogene-ngne-alzamend-neuro-alzn-and-cardiol-therapeutics-crdl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","LU0029874061.USD","XLV","BK4585","ALZN","CRDL","XBI","BK4588","NGNE","LU0128526141.USD","BK4007","BK4137","BK4539","HCSG","BK4139","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624537558","title":"Cardiol Therapeutics Inc  expected to post a loss of 10 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2624537558","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624537558?lang=en_us&edition=fundamental","pubTime":"2026-04-01 04:04","pubTimestamp":1774987448,"startTime":"0","endTime":"0","summary":"Cardiol Therapeutics Inc  expected to post a loss of10cents a share - Earnings Preview Cardiol Therapeutics Inc CRDL.TO  is expected to  show no change in quarterly revenue when it reports  results on","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nL8N40J2D3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CRDL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623315199","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2623315199","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623315199?lang=en_us&edition=fundamental","pubTime":"2026-03-30 18:00","pubTimestamp":1774864800,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·INmune Bio Inc.                                 4Q      (.26)  4:05 PM. ·Dave & Buster                                   4Q       .39   4:05 PM. ·NIKE Class B                                     3Q       .29   4:15 PM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AEHR","BNZI","FDS","PHR","PRGS","LNN","KEEL","FC","BTBT","NGEN","APOG","AIRJ","CALM","IMNN","PLAY","PVLA","NEOG","ANGO","RNXT","SGMO","MKC","AYI","CRDL","BIRD","NKE","NKLR","MSM","MAZE","BYND","AIRO","AURA","BEEM","INMB","MKC.V","RH","SGML","PENG","BCAX","CAG","INV","BHST","JILL","DMAC","NCNO","NMRA","NNOX","PVH","LW","PRPL","PROP","BITF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622709803","title":"Cardiol Therapeutics Inc  expected to post a loss of 10 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2622709803","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622709803?lang=en_us&edition=fundamental","pubTime":"2026-03-28 05:17","pubTimestamp":1774646225,"startTime":"0","endTime":"0","summary":"Cardiol Therapeutics Inc  expected to post a loss of10cents a share - Earnings Preview Cardiol Therapeutics Inc CRDL.TO  is expected to  show no change in quarterly revenue when it reports  results on","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nL8N40F24A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CRDL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622847966","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2622847966","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622847966?lang=en_us&edition=fundamental","pubTime":"2026-03-27 18:00","pubTimestamp":1774605600,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·SBC Med Grp Hld                                  4Q       .12       BMO. ·INmune Bio Inc                                  4Q      (.26)  4:05 PM. ·Banzai Intl Cl A                                4Q      (.59)      AMC. ·FactSet Res Sys                                  2Q      4.38   6:00 AM. ·McCormick & Co                                 1Q       .60   6:30 AM","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNXT","BHST","CRDL","AYI","BTBT","DEFT","INMB","NEOG","IMNN","NGEN","BCAX","KEEL","NKLR","BEEM","MKC","AEHR","ANGO","HUMA","AIRJ","BIRD","BITF","CAG","CALM","LNN","AIRO","AURA","CCL","JILL","MKC.V","MSLE","APOG","LW","MSM","NCNO","AUTL","BYND","FDS","KOPN","NKE","NMRA","PLAY","PHR","PENG","INV","KYTX","LGN","PRGS","DMAC","FC","ATOS","BNZI"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cardiolrx.com","stockEarnings":[{"period":"1week","weight":-0.0699},{"period":"1month","weight":-0.135},{"period":"3month","weight":0.6635},{"period":"6month","weight":0.384},{"period":"1year","weight":0.5872},{"period":"ytd","weight":0.8138}],"compareEarnings":[{"period":"1week","weight":0.006},{"period":"1month","weight":0.0017},{"period":"3month","weight":0.0524},{"period":"6month","weight":0.2099},{"period":"1year","weight":0.1605},{"period":"ytd","weight":0.125}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase II multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38 injection for subcutaneous administration that is in preclinical development for the treatment of heart failure. It has a license agreement with Meros. The company was incorporated in 2017 and is headquartered in Oakville, Canada.","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.185232},{"month":2,"riseRate":0.4,"avgChangeRate":0.047644},{"month":3,"riseRate":0.2,"avgChangeRate":-0.025014},{"month":4,"riseRate":0.8,"avgChangeRate":0.086779},{"month":5,"riseRate":0.6,"avgChangeRate":0.077993},{"month":6,"riseRate":0.4,"avgChangeRate":0.00664},{"month":7,"riseRate":0.8,"avgChangeRate":0.115298},{"month":8,"riseRate":0.4,"avgChangeRate":0.00902},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.044964},{"month":10,"riseRate":0.2,"avgChangeRate":-0.130762},{"month":11,"riseRate":0.2,"avgChangeRate":-0.130708},{"month":12,"riseRate":0,"avgChangeRate":-0.093352}],"exchange":"NASDAQ","name":"Cardiol Therapeutics Inc","nameEN":"Cardiol Therapeutics Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cardiol Therapeutics Inc(CRDL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Cardiol Therapeutics Inc(CRDL) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Cardiol Therapeutics Inc,CRDL,Cardiol Therapeutics Inc股票,Cardiol Therapeutics Inc股票老虎,Cardiol Therapeutics Inc股票老虎国际,Cardiol Therapeutics Inc行情,Cardiol Therapeutics Inc股票行情,Cardiol Therapeutics Inc股价,Cardiol Therapeutics Inc股市,Cardiol Therapeutics Inc股票价格,Cardiol Therapeutics Inc股票交易,Cardiol Therapeutics Inc股票购买,Cardiol Therapeutics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cardiol Therapeutics Inc(CRDL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Cardiol Therapeutics Inc(CRDL) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}